Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (54)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gutmann, D. H.
Right arrow Articles by Saporito-Irwin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutmann, D. H.
Right arrow Articles by Saporito-Irwin, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 7, 335-345, Copyright © 1998 by Oxford University Press


ARTICLES

Defects in neurofibromatosis 2 protein function can arise at multiple levels

DH Gutmann, RT Geist, Hm Xu, JS Kim and S Saporito-Irwin
Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA. gutmannd@neuro.wustl.edu

Neurofibromatosis 2 (NF2) is an inherited cancer syndrome resulting from mutations in the NF2 tumor suppressor gene. Analysis of NF2 mutations has revealed some general genotype-phenotype correlations. Severe disease has been associated with mutations that produce a premature termination while more mild disease has been associated with missense mutations. Here, we provide experimental proof for these genotype-phenotype correlations by demonstrating that nonsense mutations fail to produce stable merlin protein while missense mutations result in the generation of merlin proteins defective in negative growth regulation. This inability to suppress cell growth may result from defects in the function of merlin at several levels, including failure to form an intramolecular complex. Based on these findings, we propose a model for merlin growth suppression that provides a framework for analyzing NF2 patient mutations and merlin function.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Vet PatholHome page
P. J. Dickinson, E. I. Surace, M. Cambell, R. J. Higgins, C. M. Leutenegger, A. W. Bollen, R. A. LeCouteur, and D. H. Gutmann
Expression of the Tumor Suppressor Genes NF2, 4.1B, and TSLC1 in Canine Meningiomas
Vet. Pathol., September 1, 2009; 46(5): 884 - 892.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. S. Houshmandi, R. J. Emnett, M. Giovannini, and D. H. Gutmann
The Neurofibromatosis 2 Protein, Merlin, Regulates Glial Cell Growth in an ErbB2- and Src-Dependent Manner
Mol. Cell. Biol., March 15, 2009; 29(6): 1472 - 1486.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
M E Baser, L Kuramoto, R Woods, H Joe, J M Friedman, A J Wallace, R T Ramsden, S Olschwang, E Bijlsma, M Kalamarides, et al.
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2
J. Med. Genet., July 1, 2005; 42(7): 540 - 546.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Rong, X. Tang, D. H. Gutmann, and K. Ye
Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L
PNAS, December 28, 2004; 101(52): 18200 - 18205.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. Lallemand, M. Curto, I. Saotome, M. Giovannini, and A. I. McClatchey
NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions
Genes & Dev., May 1, 2003; 17(9): 1090 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C.-X. Sun, C. Haipek, D. R. Scoles, S. M. Pulst, M. Giovannini, M. Komada, and D. H. Gutmann
Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate
Hum. Mol. Genet., December 1, 2002; 11(25): 3167 - 3178.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. D. Sperfeld, C. Hein, J. M. Schroder, A. C. Ludolph, and C. O. Hanemann
Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2
Brain, May 1, 2002; 125(5): 996 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. M. M. Schulze, C. O. Hanemann, H. W. Muller, and H. Hanenberg
Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis
Hum. Mol. Genet., January 1, 2002; 11(1): 69 - 76.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. H. Gutmann, A. C. Hirbe, and C. A. Haipek
Functional analysis of neurofibromatosis 2 (NF2) missense mutations
Hum. Mol. Genet., July 1, 2001; 10(14): 1519 - 1529.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H. Morrison, L. S. Sherman, J. Legg, F. Banine, C. Isacke, C. A. Haipek, D. H. Gutmann, H. Ponta, and P. Herrlich
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44
Genes & Dev., April 15, 2001; 15(8): 968 - 980.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
D. H. Gutmann
The neurofibromatoses: when less is more
Hum. Mol. Genet., April 1, 2001; 10(7): 747 - 755.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. H. Gutmann, C. A. Haipek, S. P. Burke, C.-X. Sun, D. R. Scoles, and S. M. Pulst
The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the 'open' conformation and suppresses cell growth and motility
Hum. Mol. Genet., April 1, 2001; 10(8): 825 - 834.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E Brault, A Gautreau, M Lamarine, I Callebaut, G Thomas, and L Goutebroze
Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain
J. Cell Sci., January 5, 2001; 114(10): 1901 - 1912.
[Abstract] [PDF]


Home page
J. Med. Genet.Home page
D G. R Evans, M Sainio, and M. E Baser
Neurofibromatosis type 2
J. Med. Genet., December 1, 2000; 37(12): 897 - 904.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
D. R. Scoles, D. P. Huynh, M. S. Chen, S. P. Burke, D. H. Gutmann, and S.-M. Pulst
The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate
Hum. Mol. Genet., July 1, 2000; 9(11): 1567 - 1574.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Goutebroze, E. Brault, C. Muchardt, J. Camonis, and G. Thomas
Cloning and Characterization of SCHIP-1, a Novel Protein Interacting Specifically with Spliced Isoforms and Naturally Occurring Mutant NF2 Proteins
Mol. Cell. Biol., March 1, 2000; 20(5): 1699 - 1712.
[Abstract] [Full Text]


Home page
J. Med. Genet.Home page
C. LÓPEZ-CORREA, J. ZUCMAN-ROSSI, H. BREMS, G. THOMAS, and E. LEGIUS
NF2 gene deletion in a family with a mild phenotype
J. Med. Genet., January 1, 2000; 37(1): 75 - 77.
[Full Text]


Home page
Genes Dev.Home page
M. Giovannini, E. Robanus-Maandag, M. Niwa-Kawakita, M. van der Valk, J. M. Woodruff, L. Goutebroze, P. Mérel, A. Berns, and G. Thomas
Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein
Genes & Dev., April 15, 1999; 13(8): 978 - 986.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.